TerrAscend (TSNDF) Non-Current Deferred Tax Liability (2021 - 2026)
TerrAscend (TSNDF) reported Non-Current Deferred Tax Liability of $8.3 million for Q1 2026, down 6.3% year-over-year from $8.9 million in Q1 2025, and up 3.74% quarter-over-quarter from $8.0 million in Q4 2025.
TerrAscend (TSNDF) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $8.3 million in Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $8.3 million, down 6.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.3 million (down 6.3% YoY), and the FY2025 annual result was $8.0 million, down 4.78% from the prior year.
- Non-Current Deferred Tax Liability grew to $8.3 million in Q1 2026 per TSNDF's latest filing, from $8.0 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $73.1 million in Q2 2022 and troughed at $8.0 million in Q4 2025.
- A 5-year average of $26.1 million and a median of $16.9 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2022 and 2024: Non-Current Deferred Tax Liability jumped 115.15% in 2022, then slumped 57.68% in 2024.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $30.7 million in 2022, then slumped by 44.06% to $17.2 million in 2023, then tumbled by 50.93% to $8.4 million in 2024, then fell by 4.78% to $8.0 million in 2025, then climbed by 3.74% to $8.3 million in 2026.
- Business Quant data shows TSNDF's Non-Current Deferred Tax Liability at $8.3 million in Q1 2026, $8.0 million in Q4 2025, and $8.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.33 Mn |
| Mar 31, 2026 | 8.33 Mn |
| Dec 31, 2025 | 8.03 Mn |
| Dec 31, 2025 | 8.03 Mn |
| Sep 30, 2025 | 8.72 Mn |
| Sep 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Mar 31, 2025 | 8.89 Mn |
| Mar 31, 2025 | 8.89 Mn |
| Dec 31, 2024 | 8.43 Mn |
| Dec 31, 2024 | 8.43 Mn |
| Sep 30, 2024 | 16.19 Mn |
| Sep 30, 2024 | 16.19 Mn |
| Jun 30, 2024 | 16.76 Mn |
| Jun 30, 2024 | 16.76 Mn |
| Mar 31, 2024 | 16.92 Mn |
| Mar 31, 2024 | 16.92 Mn |
| Dec 31, 2023 | 17.18 Mn |
| Dec 31, 2023 | 17.18 Mn |